Aura Biosciences (AURA) EBT (2020 - 2026)
Aura Biosciences (AURA) posted EBT of -$33.7 million for Q1 2026, down 141.39% on a QoQ basis from $81.4 million in Q4 2025, and down 22.61% year-over-year from -$43.5 million in Q1 2025.
Aura Biosciences (AURA) EBT (2020 - 2026) Analysis & Trends
Aura Biosciences' EBT history runs 7 years deep, the most recent figure standing at -$33.7 million for Q1 2026.
- Quarterly EBT fell 22.61% year-over-year to -$33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 94.31% YoY) and the FY2025 annual result came in at $828000.0, up 100.95% from the prior year.
- EBT was -$33.7 million for Q1 2026 at Aura Biosciences, down from $81.4 million in the prior quarter.
- Across five years, EBT topped out at $81.4 million in Q4 2025 and bottomed at -$74.3 million in Q1 2022.
- A 5-year average of -$22.9 million and a median of -$22.0 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT slumped 1135.3% — and 2025, when it soared 415.25%.
- Aura Biosciences' EBT stood at -$18.4 million in 2022, then dropped by 19.66% to -$22.0 million in 2023, then dropped by 17.35% to -$25.8 million in 2024, then surged by 415.25% to $81.4 million in 2025, then tumbled by 141.39% to -$33.7 million in 2026.
- Business Quant data shows AURA's EBT at -$33.7 million in Q1 2026, $81.4 million in Q4 2025, and -$26.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -33.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.67 Mn |
| Dec 31, 2025 | 81.37 Mn |
| Sep 30, 2025 | -26.10 Mn |
| Jun 30, 2025 | -26.97 Mn |
| Mar 31, 2025 | -27.47 Mn |
| Dec 31, 2024 | -25.81 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Jun 30, 2024 | -20.34 Mn |
| Mar 31, 2024 | -19.66 Mn |
| Dec 31, 2023 | -21.99 Mn |
| Sep 30, 2023 | -18.51 Mn |
| Jun 30, 2023 | -18.30 Mn |
| Mar 31, 2023 | -17.47 Mn |
| Dec 31, 2022 | -18.38 Mn |
| Sep 30, 2022 | -59.05 Mn |
| Jun 30, 2022 | -40.96 Mn |
| Mar 31, 2022 | -74.30 Mn |
| Dec 31, 2021 | -11.78 Mn |
| Sep 30, 2021 | -22.95 Mn |
| Jun 30, 2021 | -8.80 Mn |